The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia
- PMID: 33131230
- PMCID: PMC7609391
- DOI: 10.5217/ir.2020.00121
The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study.Intest Res. 2020 Oct;18(4):430-437. doi: 10.5217/ir.2019.00099. Epub 2020 Sep 29. Intest Res. 2020. PMID: 32988164 Free PMC article.
References
-
- Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Prim Care. 2017;44:673–692. - PubMed
-
- Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640. - PubMed
-
- Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769–2778. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
